Inventiva(IVEVF)
DAIX, France
BiotechnologyFocus: Small Molecules
Inventiva is a life sciences company focused on Small Molecules.
Infectious DiseasesMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Global Research Initiative for Patients Screening on MASH
MASHMoxifloxacin
Healthy SubjectsClinical Trials (1)
NCT03866369Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose
Phase 1Phase 2
Clinical Trials (1)
NCT03008070Phase 2b Study in NASH to Assess IVA337
Phase 2Lanifibranor
Nonalcoholic Fatty Liver Disease (NAFLD)Clinical Trials (1)
NCT03459079Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
Phase 2Phase 2
Clinical Trials (1)
NCT05232071Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus
Phase 2IVA337
Scleroderma, DiffuseClinical Trials (1)
NCT02503644Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis
Phase 2Odiparcil
Mucopolysaccharidosis VIClinical Trials (1)
NCT03370653A Study in MPS VI to Assess Safety and Efficacy of Odiparcil
Phase 2Phase 3
Clinical Trials (1)
NCT04849728A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 7 clinical trials